Literature DB >> 2302200

The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier.

R J Boado1, W M Pardridge.   

Abstract

The brain-type glucose transporter (bGT) is assumed to be distributed among neurons and glial cells, but to be particularly enriched in brain microvascular endothelium, which makes up the blood-brain barrier (BBB) in vivo. However, in the course of the present studies it was found that the bGT is specifically expressed at the BBB in brain. The relative abundance of bGT and actin (used as a control) mRNAs were measured in bovine brain, brain capillaries, and capillary-depleted brain. Northern blot analysis showed that the bGT 2.9 Kb mRNA was increased 21-fold in brain capillaries as compared to total brain, and it was not detected in capillary-depleted brain even after overexposure of the film. This study demonstrates that i) the bGT is specifically expressed at the BBB in brain, ii) the bGT transcript in total brain represents only dilution of the capillary or BBB glucose transporter transcript, and iii) as yet unidentified glucose transporters are likely expressed in neurons and in glial cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302200     DOI: 10.1016/0006-291x(90)91927-k

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Purification of Mouse Brain Vessels.

Authors:  Anne-Cécile Boulay; Bruno Saubaméa; Xavier Declèves; Martine Cohen-Salmon
Journal:  J Vis Exp       Date:  2015-11-10       Impact factor: 1.355

Review 2.  Blood-brain barrier and new approaches to brain drug delivery.

Authors:  W M Pardridge; R J Boado; K L Black; P A Cancilla
Journal:  West J Med       Date:  1992-03

Review 3.  Drug transport across the blood-brain barrier.

Authors:  William M Pardridge
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-29       Impact factor: 6.200

4.  Effects of dexamethasone in vivo and in vitro on hexose transport in brain microvasculature.

Authors:  S R Chipkin; A van Bueren; E Bercel; C R Garrison; A L McCall
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

5.  Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study.

Authors:  C L Farrell; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

6.  Dehydroascorbic Acid Promotes Cell Death in Neurons Under Oxidative Stress: a Protective Role for Astrocytes.

Authors:  Andrea García-Krauss; Luciano Ferrada; Allisson Astuya; Katterine Salazar; Pedro Cisternas; Fernando Martínez; Eder Ramírez; Francisco Nualart
Journal:  Mol Neurobiol       Date:  2015-10-26       Impact factor: 5.590

7.  Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines.

Authors:  L Juillerat-Jeanneret; A Aguzzi; O D Wiestler; P Darekar; R C Janzer
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug

8.  Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family.

Authors:  R J Boado; W M Pardridge; H V Vinters; K L Black
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  Blood-brain glucose transfer in the mouse.

Authors:  E M Cornford; D Young; J W Paxton; S Hyman; C L Farrell; R B Elliott
Journal:  Neurochem Res       Date:  1993-05       Impact factor: 3.996

Review 10.  Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.

Authors:  Sumio Ohtsuki; Tetsuya Terasaki
Journal:  Pharm Res       Date:  2007-07-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.